J. Goldman & Co LP Invests $10.25 Million in Danaher Corporation $DHR

J. Goldman & Co LP acquired a new stake in Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 53,828 shares of the conglomerate’s stock, valued at approximately $10,253,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of DHR. BlackRock Inc. acquired a new stake in shares of Danaher in the 2nd quarter valued at approximately $10,492,520,000. State Street Corp boosted its position in Danaher by 1.7% in the fourth quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock valued at $6,345,529,000 after buying an additional 472,608 shares in the last quarter. Capital International Investors grew its stake in shares of Danaher by 8.9% during the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after buying an additional 1,487,768 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Danaher by 9.1% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after buying an additional 1,334,221 shares in the last quarter. Finally, Wellington Management Group LLP lifted its stake in shares of Danaher by 11.2% in the 4th quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock valued at $3,451,380,000 after acquiring an additional 1,517,904 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 0.3%

NYSE DHR opened at $215.78 on Wednesday. The firm has a market capitalization of $151.69 billion, a PE ratio of 38.33, a price-to-earnings-growth ratio of 2.68 and a beta of 0.78. The business’s 50-day moving average price is $197.17 and its two-hundred day moving average price is $192.36. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same period last year, the company earned $0.77 earnings per share. The firm’s revenue was up 5.5% compared to the same quarter last year. On average, analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on DHR. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 price objective on shares of Danaher in a research report on Wednesday, July 22nd. HSBC reduced their price target on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Wolfe Research downgraded shares of Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. Guggenheim reduced their target price on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Finally, Weiss Ratings upgraded shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average price target of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.